Asset Details
Do you wish to reserve the book?
Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity
Do you wish to request the book?
Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity
2024
Overview
Excess adiposity is a reversible etiologic risk factor for obstructive sleep apnea. In this trial, tirzepatide reduced the apnea–hypopnea index of participants with obstructive sleep apnea and obesity.
Publisher
Massachusetts Medical Society
Subject
/ Adult
/ Apnea
/ Blood Pressure - drug effects
/ C-Reactive Protein - analysis
/ Female
/ Gastric Inhibitory Polypeptide - administration & dosage
/ Gastric Inhibitory Polypeptide - adverse effects
/ Glucagon-Like Peptide-1 Receptor Agonists - administration & dosage
/ Glucagon-Like Peptide-1 Receptor Agonists - adverse effects
/ Humans
/ Hypoxia
/ Male
/ Obesity
/ Outpatient-Based Clinical Medicine
/ Patients
/ Placebos
/ Sleep
/ Sleep Apnea, Obstructive - blood
/ Sleep Apnea, Obstructive - diagnosis
/ Sleep Apnea, Obstructive - drug therapy
